nimodipine has been researched along with Ear Neoplasms in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Ear Neoplasms: Tumors or cancer of any part of the hearing and equilibrium system of the body (the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scheller, C | 1 |
Vogel, AS | 1 |
Simmermacher, S | 1 |
Rachinger, JC | 1 |
Prell, J | 1 |
Strauss, C | 1 |
Reinsch, M | 1 |
Kunter, U | 1 |
Wienke, A | 1 |
Neumann, J | 1 |
Scheller, K | 1 |
1 other study available for nimodipine and Ear Neoplasms
Article | Year |
---|---|
Prophylactic intravenous nimodipine treatment in skull base surgery: pharmacokinetic aspects.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, General; Blood Pressure; Calcium Channel Blockers; Chrom | 2012 |